OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $548,576 | +17.1% | 142,858 | +0.0% | 0.00% | – |
| Q2 2023 | $468,509 | +27.1% | 142,838 | 0.0% | 0.00% | – |
| Q1 2023 | $368,522 | +549932.8% | 142,838 | +300.1% | 0.00% | – |
| Q4 2022 | $67 | -99.9% | 35,704 | -14.4% | 0.00% | – |
| Q3 2022 | $77,000 | +26.2% | 41,720 | +113.2% | 0.00% | – |
| Q1 2022 | $61,000 | -3.2% | 19,564 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -79.2% | 19,564 | -63.0% | 0.00% | – |
| Q3 2020 | $303,000 | -22.1% | 52,819 | 0.0% | 0.00% | – |
| Q2 2020 | $389,000 | +111.4% | 52,819 | -14.5% | 0.00% | – |
| Q1 2020 | $184,000 | -51.1% | 61,794 | -31.9% | 0.00% | – |
| Q4 2019 | $376,000 | +27.9% | 90,701 | 0.0% | 0.00% | – |
| Q3 2019 | $294,000 | +75.0% | 90,701 | 0.0% | 0.00% | – |
| Q2 2019 | $168,000 | +4.3% | 90,701 | 0.0% | 0.00% | – |
| Q1 2019 | $161,000 | -23.7% | 90,701 | +3.9% | 0.00% | – |
| Q4 2018 | $211,000 | -52.5% | 87,257 | +11.5% | 0.00% | – |
| Q3 2018 | $444,000 | – | 78,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |